Sleep Disorders News

Dupilumab significantly improved sleep quality, reducing the number of times patients with atopic dermatitis woke up in the middle of the night with pain and itchiness, according to a study.

Alpha-gal sensitization did not appear prevalent among patients with chronic urticaria, with few patients experiencing clinically relevant alpha-gal allergy, according to a letter published in Clinical and Translational Allergy.

Although patients with asthma and other atopic conditions experience higher risks for sleep disorders, allergists vary in how they address their patients’ sleep, according to findings presented in a research letter.

Patients with chronic rhinosinusitis with nasal polyps experienced improved sleep and functioning after 52 weeks of treatment with dupilumab, according to research published in The Journal of Allergy and Clinical Immunology: In Practice.

Patients with chronic spontaneous urticaria who used ligelizumab reported improvements in their sleep quality compared with patients who received omalizumab or placebo, according to a study published in Clinical and Translational Allergy.

PHOENIX — Young children with atopic dermatitis demonstrated a significant disease burden impacting their quality of life, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Septal deviation may be a treatable trait of asthma, with septoplasty reducing the risk, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

African American patients with chronic rhinosinusitis had worse sleep quality even after treatment compared with their white counterparts, according to results of a prospective cohort study.

Researchers found that the circadian system contributes to the common nighttime worsening of asthma, according to data published in Proceedings of the National Academy of Sciences of the United States of America.